Ivermectin

Originally an anti-parasitic drug, Ivermectin has shown potential as a cancer treatment. Preclinical studies suggest that it may inhibit the proliferation of cancer cells, although more research is needed to confirm its effectiveness.

• The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug - PMC
• Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin - PMC